Patients with longstanding primary antiphospholipid syndrome: Retrospective analysis of organ damage and mortality

Lupus

Volumn 23, Issue 12, 2014, Pages 1255-1258

  Dall'ara, F ^a,b   Reggia, R ^a,b   Taraborelli, M ^a,b   Andreoli, L ^a,b   Taglietti, M ^b   Frassi, M ^b   Franceschini, F ^b   Tincani, A ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b SPEDALI CIVILI   (Italy)

Author keywords

mortality; organ damage; outcome; Primary antiphospholipid syndrome

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLEEDING; BREAST CARCINOMA; CAUCASIAN; CLINICAL ARTICLE; COLITIS; COLON CARCINOMA; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; ECCHYMOSIS; EPISTAXIS; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; GASTROINTESTINAL TRACT; GINGIVA BLEEDING; HOSPITALIZATION; HUMAN; INTESTINE ISCHEMIA; LEGIONELLA; LEGIONELLA PNEUMONIA; LIVE BIRTH; MALE; MEDICAL RECORD; METRORRHAGIA; MIDDLE AGED; MORTALITY; ONSET AGE; PNEUMONIA; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDY; SEPSIS; SJOEGREN SYNDROME; SUBDURAL HEMATOMA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; AGED; COMPLICATION; CONNECTIVE TISSUE DISEASES;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84908668180     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314534308     Document Type: Conference Paper

References (10)

1. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
2. Pierangeli SS, de Groot PG, Dlott J, et al. 'Criteria' aPL tests: Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus. 2011 ; 20: 182-190
3. Erkan D, Yazici Y, Sobel R, et al. Primary antiphospholipid syndrome: functional outcome after 10 years. J Rheumatol. 2000 ; 27: 2817-2821
4. Cervera R, Serrano R, Pons-Estel GJ, et al., on behalf of the Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies). Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: A multicentre prospective study of 1000 patients. Ann Rheum Dis 2014 (Epub ahead of print) doi:101136/annrheumdis-2013-204838.
5. Grika EP, Ziakas PD, Zintzaras E, et al. Morbidity, mortality, and organ damage in patients with antiphospholipid syndrome. J Rheumatol. 2012 ; 39: 516-523
6. Tektonidou MG, Varsou N, Kotoulas G, et al. Cognitive deficits in patients with antiphospholipid syndrome: Association with clinical, laboratory, and brain magnetic resonance imaging findings. Arch Intern Med. 2006 ; 166: 2278-2284
7. Stoll T, Seifert B, Isenberg DA. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol. 1996 ; 35: 248-254
8. Barbhaiya M, Erkan D, Rodriguez-Almaraz E, et al. Utility of the Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index for antiphospholipid antibody (aPL) positive patients. [Abstract.] Arthritis Rheum 2011; 63(Suppl. S3).
9. Amigo MC, Barile LA, Barragan A, et al. Development and initial validation of a chronic damage index in patients with antiphospholipid syndrome. [Abstract.] Arthritis Rheum 2011; 63(Suppl:S3).
10. Andreoli L, Pregnolato F, Burlingame RW, et al. Antinucleosome antibodies in primary antiphospholipid syndrome: A hint at systemic autoimmunity?. J Autoimmun. 2008 ; 30: 51-57